Interaction of the dopaminergic and serotonergic systems in rat brain: Studies in parkinsonian models and brain microdialysis (Dopaminergisen ja serotonergisen järjestelmän vuorovaikutus rotan aivoissa: tutkimuksia Parkinson- ja mikrodialyysimalleissa)
Year: 2008
Type: dissertation
Abstract: Dopamine and serotonin (5-hydroxytryptamine; 5-HT) are involved in several essential brain functions as well as in various neurological and mental disorders.Anatomical, electrophysiological and biochemical data point to an important interplay of the serotonergic and dopaminergic pathways.In particular, the serotonergic system has a modulatory role of on dopaminergic neurotransmission in the central nervous system (CNS).Various 5-HT receptor subtypes modulate dopamine release both directly by 5-HT receptors located on dopaminergic neurons, and indirectly via 5-HT heteroreceptors present on GABAergic neurons.Brain 5-HT/dopamine interactions are also putative targets for drug therapies in disorders related to alterations in dopaminergic or serotonergic neurotransmission, such as Parkinson's disease (PD), schizophrenia and depression.However, the mechanisms to explain the interactions between 5-HT and dopamine in these brain dysfunctions are not well defined.The objectives of this study were 1) to explore the role of striatal 5-HT in the unilateral rat model of PD, and 2) to assess the ability of 5-HT 2A/2C and 5-HT 1A receptor ligands to modulate accumbal and striatal dopamine release and metabolism in normal rats.Also 3) the advantages and disadvantages of two types of 6-hydroxydopamine (6-OHDA)-lesion models were evaluated in neuroprotection studies with a flavonoid, quercetin.It was shown that acute intrastriatal L-dopa infusion decreased contralateral rotation of unilaterally 6-OHDA-lesioned rats, evidently by desensitization of ipsilateral dopamine D 2 receptors.In an acute study, the decrease in the amount of rotations and imbalance of striatal 5-HT levels between intact and lesion side were abolished by inhibition of 5-HT synthesis.In a long-term study, continuous 2week intrastriatal L-dopa infusion in 6-OHDA-rats also decreased the number of contralateral rotations induced by peripheral L-dopa and induced marked alterations in the ipsilateral serotonergic system (such as a long-term increase in 5-HT synthesizing enzyme tryptophan hydroxylase) as assessed on day 70 postinfusion.In normal rats, the anxiolytic 5-HT 2A/2C antagonist, deramciclane, had an antidopaminergic effect similar to that of neuroleptics or the anxiolytic 5-HT 1A agonist buspirone at a high dose.At least a 5-fold margin was found between the anxiolytic and neuroleptic doses of deramciclane in the rat.Striatal 5-HT content was differently affected by the two types of unilateral 6-OHDA-lesion models.Since it is known that striatal 5-HT is reduced in PD patients, it seems that the 6-OHDA medial forebrain bundlelesioned rat models this situation unilaterally rather well.In these models, quercetin had no effect indicative of neuroprotection against nigrostriatal dopaminergic or serotonergic 6-OHDA-induced neuron damage in vivo.In conclusion, these results highlight the role of 5-HT neurons in the striatal dopaminergic imbalance that is responsible for the rotational behavior seen in the unilateral 6-OHDA rat.This study provides new information about the serotonergic effects after local exogenous L-dopa in acute and long-term administrations into the striatum of dopamine depleted rat.The results may help to further clarify the role of the serotonergic system in the action of L-dopa under dopamine deficiency.Additionally, the clear unilateral 5-HT damage in this widely used rat model should be taken into account in further studies.This study also confirms earlier reports of dopamine modulating properties of 5-HT 1A and 5-HT 2A/2C ligands, particularly in the mesolimbic system, and provides further evidence that combined affinity of 5-HT/ dopamine D 2 receptors may be beneficial in drug actions modulating dopaminergic tone in the CNS.The lack of effect of quercetin in 6-OHDA-rats casts serious doubt on the neuroprotective effects of this bioflavonoid in experimental PD in vivo.
Author: Tiina M. Kääriäinen
Institution: University of Eastern Finland
Language: Finnish
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: Helsingin Yliopisto
OpenAlex ID: W3096322966
